Aurobindo Pharma Approves 700% Interim Dividend for FY27
Aurobindo Pharma Ltd 路 Dividend 路 05 Nov 2026, 1:46 am
Aurobindo Pharma Approves 700% Interim Dividend for FY27 Aurobindo Pharma鈥檚 Board of Directors has declared an interim dividend of 700%, translating to Rs. 7.00 per equity share with a face value of Re. 1.00 for FY27. The company has fixed 11th Nov'26 as the record date to determine shareholder eligibility. The interim dividend is scheduled to be paid on or before 20th Nov'26.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. 路 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. 路 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". 路 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. 路 09 Nov 2026
- Intimation of investor / analysts meet to be held on 16.09.2026. 路 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. 路 05 Nov 2026
- Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company. 路 05 Nov 2026
